These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3815910)

  • 1. Low protein diet and 1,25 (OH)2 D3 levels.
    Lindenau K; Fröhling PT
    Clin Nephrol; 1987 Jan; 27(1):47-8. PubMed ID: 3815910
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
    Chesney RW; Hamstra AJ; Phelps M; DeLuca HF
    Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of calcitriol during treatment with protein-reduced diet in patients with renal failure.
    Wilske J; Attman PO
    Nephron; 1994; 66(4):421-5. PubMed ID: 8015645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.
    Tareen N; Martins D; Zadshir A; Pan D; Norris KC
    Ethn Dis; 2005; 15(4 Suppl 5):S5-102-6. PubMed ID: 16315388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
    Long JF; Nagode LA; Steinmeyer CL; Renkes G
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):3-14. PubMed ID: 8165367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in guinea pigs: exacerbation of bone phenotype during pregnancy and disturbed fetal mineralization, with recovery by 1,25(OH)2D3 infusion or dietary calcium-phosphate supplementation.
    Rummens K; van Bree R; Van Herck E; Zaman Z; Bouillon R; Van Assche FA; Verhaeghe J
    Calcif Tissue Int; 2002 Oct; 71(4):364-75. PubMed ID: 12196905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 25-hydroxycholecalciferol in Greek uremics.
    Drivas G; Bamias J; Tsomis A; Kalos A; Douratsos D; Melissinos K
    Invest Urol; 1980 Jul; 18(1):52-3. PubMed ID: 7410014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance.
    Schmidt-Gayk H; Bouillon R; Roth HJ
    Scand J Clin Lab Invest Suppl; 1997; 227():35-45. PubMed ID: 9127467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients.
    Matias PJ; Ferreira C; Jorge C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
    Nephrol Dial Transplant; 2009 Feb; 24(2):611-8. PubMed ID: 18775809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease].
    Spustová V; Dzúrik R
    Vnitr Lek; 2004 Jul; 50(7):537-43. PubMed ID: 15323262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levels of dihydroxyvitamin D3 and hydroxyvitamin D in patients with chronic renal insufficiency].
    Lazarević M; Poskurica M; Djukanović Lj; Babić Lj; Metiljević S
    Srp Arh Celok Lek; 1996; 124 Suppl 1():108-11. PubMed ID: 9102866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
    Theiler R; Bischoff H; Tyndall A; Stähelin HB
    Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The low-protein diet. The potentials and limits in treating chronic kidney failure].
    Picco D; Codardini M
    Prof Inferm; 1990; 43(2):41-6. PubMed ID: 2118256
    [No Abstract]   [Full Text] [Related]  

  • 19. Low protein diet, designed as a 'self-selected' diet.
    Uddebom G
    Contrib Nephrol; 1990; 81():25-8. PubMed ID: 2093505
    [No Abstract]   [Full Text] [Related]  

  • 20. Low protein diet and progression of chronic renal failure. 1st scientific meeting of the European Study Group for the Conservative Management of Chronic Renal Failure. Heidelberg, November 7-8, 1985.
    Contrib Nephrol; 1986; 53():1-146. PubMed ID: 3802818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.